Yale School of Medicine Names Jack Elias Chair of Internal Medicine

Jack A. Elias, M.D. Jack A. Elias, M.D., the Waldemar Von Zedtwitz Professor of Medicine and chief of the Section of Pulmonary and Critical Care Medicine, has been appointed chair of the Department of Internal Medicine.
Jack A. Elias, M.D.

Jack A. Elias, M.D., the Waldemar Von Zedtwitz Professor of Medicine and chief of the Section of Pulmonary and Critical Care Medicine, has been appointed chair of the Department of Internal Medicine.

A leading authority on the molecular basis of asthma and other lung disorders, Elias will lead the school’s largest department with 351 full-time faculty, $83 million in research funding, and $45 million in clinical activity.

Elias, who is board certified in internal medicine, pulmonary disease, allergy and immunology and critical care medicine, came to Yale in 1990 as professor and chief of pulmonary and critical care medicine. He began his academic career at the University of Pennsylvania.

Elias’s research is focused on the cellular and molecular biology of the lung, and processes related to both injury and repair. He has studied asthma, emphysema, pulmonary fibrosis and acute lung injury. His research group has developed and studied genetic models of these diseases and translated findings in these models to human disorders. This work has validated therapeutic targets for pharmaceutical companies seeking to develop new therapies for these conditions.

“Elias is a respected clinician and leading authority in his field of research,” said School of Medicine Dean Robert Alpern. “He has been a distinguished member of the School of Medicine faculty for over 16 years and I look forward to working with him to achieve the many goals of the Department of Internal Medicine.”

Elias, who has trained more than 50 investigators now working in academia and industry, has seven patents or pending patents based on his research. He has been a member of the Association of American Physicians since 1998 and a councilor since 2003. He has held more than a dozen posts for the American Thoracic Society/American Lung Association, including chairmanship of its long-range planning and scientific advisory committees and of the Scientific Assembly on Allergy, Immunology and Inflammation. He is also a participant in strategic planning for the National Heart, Lung and Blood Institute.

He is the author of more than 160 original journal articles and 200 abstracts and is co-editor of the textbook “Fishman’s Pulmonary Diseases and Disorders.” He is principal investigator of four current R01 awards, a T32 training grant, and a P01 program project grant from the National Institutes of Health.

Elias received his undergraduate and medical degrees from the University of Pennsylvania and was an intern and resident at Tufts-New England Medical Center in Boston. He returned to Penn as a senior resident and completed fellowships there in both allergy and immunology and in cardiovascular-pulmonary medicine.

“I would like to express gratitude to David Coleman, M.D., for his extraordinary leadership as interim chair,” Alpern said. “Dr. Coleman, who assumes the chairmanship of medicine this month at Boston University, will be very much missed.”

Share this with Facebook Share this with X Share this with LinkedIn Share this with Email Print this

Media Contact

Karen N. Peart: karen.peart@yale.edu, 203-980-2222